Supplementary Material for: Lenvatinib as second-line treatment after atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma –clinical results show importance of hepatic reserve function

  • Atsushi Hiraoka (寄稿者)
  • Takashi Kumada (寄稿者)
  • Toshifumi Tada (寄稿者)
  • Masashi Hirooka (寄稿者)
  • Kazuya Kariyama (寄稿者)
  • Joji Tani (寄稿者)
  • Masanori Atsukawa (寄稿者)
  • Koichi Takaguchi (寄稿者)
  • Ei Itobayashi (寄稿者)
  • Shinya Fukunishi (寄稿者)
  • Kunihiko Tsuji (寄稿者)
  • Toru Ishikawa (寄稿者)
  • Kazuto Tajiri (寄稿者)
  • Hironori Ochi (寄稿者)
  • Satoshi Yasuda (寄稿者)
  • Hidenori Toyoda (寄稿者)
  • Chikara Ogawa (寄稿者)
  • Takashi Nishimura (寄稿者)
  • Takeshi Hatanaka (寄稿者)
  • Satoru Kakizaki (寄稿者)
  • Noritomo Shimada (寄稿者)
  • Kazuhito Kawata (寄稿者)
  • Atsushi Naganuma (寄稿者)
  • Hisashi Kosaka (寄稿者)
  • Tomomitsu Matono (寄稿者)
  • Hidekatsu Kuroda (寄稿者)
  • Y. Yata (寄稿者)
  • Hideko Ohama (寄稿者)
  • Fujimasa Tada (寄稿者)
  • Kazuhiro Nouso (寄稿者)
  • Asahiro Morishita (寄稿者)
  • Akemi Tsutsui (寄稿者)
  • Takuya Nagano (寄稿者)
  • Norio Itokawa (寄稿者)
  • Tomomi Okubo (寄稿者)
  • Taeang Arai (寄稿者)
  • Keisuke Yokohama (寄稿者)
  • Michitaka Imai (寄稿者)
  • Yohei Koizumi (寄稿者)
  • Shinichiro Nakamura (寄稿者)
  • Hiroko Iijima (寄稿者)
  • Masaki Kaibori (寄稿者)
  • Yoichi Hiasa (寄稿者)

データセット

  • 1 学術論文

検索結果